“ACO-SWITCH is a prospective study in adults with ATTR-CM,” wrote the researchers. “The study will determine the effects of ...
The FDA approved daraxonrasib (Rasonque), the first targeted therapy for metastatic pancreatic adenocarcinoma, citing a ...
One in 5 adults with newly diagnosed moderate to severe plaque psoriasis maintained clear or almost-clear skin a full year ...
Real-world primary care deployment achieved 93.6% successful screenings, with 1.56% requiring dilation and 27.2% referred to ophthalmology. Cost per diagnosed DR case reflected ~52% savings largely ...
Medicare Part D changes, premium stabilization expiration, and a Bridge demonstration converge with rising GLP-1 demand and costs. Medicare Part D plans are running out of easy ways to absorb the cost ...
Authors noted that a grocery assistance benefit in commercial health plans was linked to fewer diabetes complications and ...
The FDA cleared the first and only single-biomarker blood test for assessing amyloid pathology to rule in or rule out Alzheimer disease in adults aged 55 and older. 1 ...
Clinicians outline fragmented obesity and diabetes care models, insurance-driven prescribing, and early results from Medicare ...
The next episode in this series, 'Empowering Primary Care: Early Alzheimer's Detection and the Referral Pathway Challenge,' features the panelists advancing their conversation on Alzheimer's disease ...
A major factor, Bhatnagar explained, is uncompensated labor. Women faculty frequently take on mentorship, teaching, and committee responsibilities that consume significant time but go unrecognized in ...
The AACR roadmap spotlights LDCT screening, ctDNA MRD monitoring, and new NSCLC/SCLC therapies like DLL3 tarlatamab to close ...
Before nipaclaimab-aahu’s approval, there were no FDA-approved drugs specifically indicated for wAIHA. Treatment generally ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results